In addition, Sorin is investing $5m in Rainbow Medical, an Israeli medical device incubator of 10 startups founded by Yossi Gross and owner of Enopace.
Sorin Group, an Italy-based cardiac device maker, has invested $5m in Enopace Biomedical, an early-stage company developing a neuromodulation system to treat patients with heart failure, with an option to buy the Israel-based start-up.
In addition, Sorin is investing $5m in Rainbow Medical, an Israeli medical device incubator of 10 startups founded by Yossi Gross and owner of Enopace.
Rainbow Medical founded Enopace, which is led by Amir Dagan, in 2008.
Sorin previously invested an undisclosed amount in Enopace in…
